Tag: gmo

Google to Release 64 Million Bacteria-Infected Mosquitoes Across California and Florida Over the Next Two Years

Google is seeking federal approval to release up to 64 million specially treated mosquitoes across California and Florida over the next two years, according to an Environmental Protection Agency (EPA) announcement published earlier this month in The Federal Register, the official journal of the U.S. government.

The tech giant is “requesting an experimental use permit (EUP) for the Wolbachia pipientis wAlbB contained in live adult Culex quinquefasciatus male mosquitoes (DQB Strain),” according to the announcement.

A summary of the request reads:

“Google LLC is proposing to use up to 14.080 mg of the active ingredient Wolbachia pipientis wAlbB Contained in Live Adult Culex quinquefasciatus Male Mosquitoes (DQB Strain) for two years in California and Florida. In Florida, up to 16,000,000 DQB Male Mosquitoes are proposed to be released in year 1, and up to 16,000,000 released in year 2. In California, up to 16,000,000 are proposed to be released in year 1, and up to 16,000,000 released in year 2. Proposed testing will include the states of California and Florida to generate data to support a Section 3 product registration application under FIFRA.”

Keep reading

Florida Drops 800,000 Irradiated Mosquitoes from Drones Over Citizens 

A Florida government mosquito-control agency has confirmed that approximately 800,000 Aedes aegypti mosquitoes were raised in a laboratory, said to be sterilized with X-rays, and released from drones over part of Fort Myers, Florida, in what officials describe as a mosquito population-control experiment.

Aedes aegypti mosquitoes are known vectors of dengue, chikungunya, Zika, and yellow fever.

The mosquitoes are irradiated at 12 Gy per minute (12,000 mGy/min), while a human chest X-ray delivers only 0.1 mSv total—so the mosquito dose rate is 120,000 times higher than the dose a person receives in a chest X-ray.

The Florida operation was conducted at the historic Edison and Ford Winter Estates tourist site, which includes gardens, museums, and public walkways visited by civilians and families throughout the year.

Local reporting stated the release was part of an ongoing partnership between the mosquito-control district and the estates property.

The Lee County Mosquito Control District was created by the Florida Legislature in 1958 as an independent special district funded primarily through local property taxes.

That means local Florida residents are effectively funding the development and expansion of drone-based mosquito release operations over populated areas.

The mosquitoes were released using drone technology as part of the so-called Sterile Insect Technique (SIT) program.

The program’s stated goal is to suppress mosquito populations by flooding an area with sterilized male mosquitoes that mate with wild females, producing eggs that allegedly do not hatch.

Officials claim only male mosquitoes were released because male mosquitoes do not bite humans.

However, studies show these techniques still end up producing both female mosquitoes (which do bite, potentially spreading disease) and eggs that do end up hatching.

Keep reading

Re-Engineering Nature: Biotech Firm Plays God with Artificial Egg Breakthrough

A biotechnology firm’s claim that it has taken a major step toward “bringing back extinct species” is raising not only scientific debate, but deeper ethical and moral questions about humanity’s growing willingness to reshape life itself.

The company at the center of the controversy, if you want to call it that, Colossal Biosciences, says it has successfully hatched live chicks using an artificial egg system—an achievement it describes as a breakthrough.

To some, the development represents cutting-edge innovation. To others, it signals a troubling step further into territory long associated with science fiction—and, increasingly, with man attempting to take on the role of Creator.

The company says it hatched 26 chicks using a 3D-printed structure that allows embryos to develop outside a natural shell.

CEO Ben Lamm framed the project as a bold reimagining of biology itself. “We didn’t just copy nature… we tried to re-engineer it,” he said.

That statement, while celebrated in some scientific circles, is precisely what gives others pause.

Keep reading

De-Extinct Dire Wolves Ready To Breed; Bioscience Company Pushes Forward Multiple Projects

Colossal Biosciences has announced that its de-extinct dire wolves—Romulus, Remus, and Khaleesi—are now breeding-aged and the firm plans to expand the pack later this year. The development marks a significant step for the Texas-based company in its mission to restore extinct species through genetic engineering.

The dire wolf pups, born in late 2024 and early 2025, represent the world’s first de-extinct animals. They have thrived in a secure 2,000-acre preserve, reaching milestones like learning to process whole deer carcasses and now showing readiness for natural breeding behaviors.

“The dire wolf pack is actually breeding-aged at this point,” Matt James, Colossal’s chief animal officer, said, adding “But we will initially grow the pack through assisted reproduction while we create new, genetically diverse individuals.”

The company intends to engineer two to four additional pups to boost genetic diversity before allowing full natural breeding. “The plan is to create an inter-breedable population of dire wolves in which they would eventually breed naturally to create a sustainable population of the world’s first de-extinct species,” James continued.

He further added, “We will grow the population through assisted reproduction initially and then eventually only rely on natural breeding.”

“The dire wolves are doing great,” Ben Lamm, Colossal’s CEO and co-founder, stated., adding “The three dire wolves live on a 2,000-acre secure, expansive ecological preserve that allows us to monitor and manage them while providing them a semi-wild habitat to thrive in. We hope to have more dire wolf pups by the end of the year.”

Colossal reconstructed the dire wolf genome from ancient DNA fragments in bone samples, including a 72,000-year-old skull. Scientists then edited gray wolf embryos to incorporate key traits: a white coat, larger teeth, more muscular build, and distinctive howl. Embryos were implanted in surrogate dogs, with births by caesarean section.

Keep reading

Bio-Engineered Venom in our Food, Veggie Seeds, Common Drugs

The Shocking Truth About Venom Genetically-Engineered Vegetable Seeds

Imagine biting into a fresh tomato or serving up a bowl of rice, unaware that deep within the plant’s DNA lies a venom protein borrowed from a snake, scorpion, or spider. It sounds like science fiction, but it’s not.

According to a peer-reviewed study published in the journal Venoms (November 2021), scientists have been exploring ways to incorporate venom proteins into vegetable seeds as a new line of defense against insects… and those developments may already be far more widespread than the public has been told.

Venom for Dinner? The Study That Started the Alarm

The journal article, titled Applications of Venom Biodiversity in Agriculture, outlines a growing body of research in which venom peptides… proteins derived from creatures like snakes, spiders, and scorpions… are used to engineer pest-resistant plants.

The rationale?

According to the study’s authors, venom-based biotechnology holds promise for creating what they call “bioinsecticides.” The idea is that plants, through genetic-engineering, can internally produce venom proteins that repel or kill attacking pests. It’s been offered by marketers as a more “natural” solution than synthetic pesticides.

But some researchers aren’t convinced… and the backlash is growing.

Keep reading

Scientists Engineered a Plant to Produce 5 Different Psychedelics at Once

What do plants, toads, and mushrooms have in common? They can all produce psychedelic substances – and now their powers have been combined in one plant, like a trippier Captain Planet.

In a wild first, scientists have taken the genes these organisms use to make five natural psychedelics and introduced them into a tobacco plant (Nicotiana benthamiana), which then produced all five compounds simultaneously.

As interest grows in psychedelics as potential treatments for illnesses such as depression, anxiety, and PTSD, the newly developed system could offer scientists a new way to produce these compounds for research purposes.

“[Our] strategy established a heterologous plant system for the production of five prominent therapeutically valuable compounds, their derivatives, and nonnatural plant analogs, providing a starting point for their production in plants,” writes a team led by researchers at the Weizmann Institute of Science in Israel.

Tryptamine psychedelics are a class of compounds that includes psilocin, psilocybin, and a number of dimethyltryptamine (DMT) compounds. The ability to produce these substances has emerged in diverse organisms across the tree of life – plants, fungi, and animals.

In recent years, a number of studies have shown that tryptamine psychedelics may represent an untapped resource when it comes to mental health treatments.

However, progress in this field remains limited, in part due to regulatory restrictions, underscoring the need for more research. This creates practical challenges for scientists.

“Traditionally, the supply of psychedelics relies on natural producers, mainly plants, fungi, and the Sonoran Desert toad,” the researchers write.

“Harvesting these organisms for their psychoactive compounds raises ecological and ethical concerns, being increasingly threatened by habitat loss and overexploitation.”

In an effort to tackle this, plant scientists Paula Berman and Janka Höfer and their team set out to map and rebuild the biochemical pathways behind these compounds.

They identified the key genes used by two plants – Psychotria viridis and Acacia acuminata – to make DMT, and the step-by-step chemical pathways involved in producing the compound.

Keep reading

Chinese scientists have turned mosquitoes into flying vaccines — that can still bite humans

Researchers from the nation that likely unleashed COVID-19 unto the world have transformed mosquitoes into flying syringes.

Some researchers, including a group at the Bill Gates Foundation-backed Leiden University Medical Center in the Netherlands, have already attempted in recent years to fashion mosquitoes into flying vaccine delivery systems with human targets in mind.

Now, scientists at the state-controlled Chinese Academy of Sciences — an institution that has a strategic partnership with the People’s Liberation Army Academy of Military Sciences — have targeted bats, purportedly designing mosquitoes to instead deliver recombinant vesicular stomatitis virus-based rabies and Nipah vaccines to the flying mammals.

Like rabies, Nipah virus is a potentially deadly virus found in animals. Whereas rabies has nearly a 100% fatality rate in humans once symptoms manifest, the estimated case fatality rate for Nipah virus ranges from 40% to 75%.

Keep reading

GMO Wheat Sprayed With Chemical 166 Times More Toxic Than Glyphosate

A new report from Friends of the Earth raises alarm over the U.S. government’s recent approval of HB4 genetically engineered or GMO wheat, warning that it could pose serious risks to public health, the environment and U.S. farmers’ livelihoods, while offering no proven benefit.

The approval of HB4 wheat marks a critical turning point: after decades of public opposition and trade concerns that kept GMO wheat off U.S. fields, consumers now face the prospect of herbicide-tolerant wheat entering the food system.

However, it is not currently being grown commercially in the U.S.

Friends of the Earth is calling on companies and consumers to reject HB4 GMO wheat before it enters the market.

Developed by the Argentine biotechnology firm Bioceres Crop Solutions, HB4 wheat is engineered to tolerate the toxic herbicide glufosinate ammonium.

Glufosinate is banned in the European Union because it poses risks to human health. It is also linked to negative impacts on soil and ecosystem health.

“GMO wheat poses high risks with no clear benefits. It threatens farmers, consumers, and ecosystems,” said Dana Perls, senior program manager at Friends of the Earth.

“Companies and consumers should reject genetically engineered wheat and support proven, sustainable solutions. Organic farming and traditional breeding protect climate, biodiversity, and food security — without toxic trade-offs.”

The report unpacks the regulatory gaps, health implications, environmental concerns and trade risks at stake.

Key findings include:

We’ve been here before — and it failed

HB4 wheat is not innovation; it is a repetition of a well-documented failure — the chemical-dependent model introduced with Monsanto’s “Roundup Ready” crops in the 1990s.

GMO crops have driven massive increases in herbicide use, spawned herbicide-resistant superweeds and trapped farmers on a costly pesticide treadmill.

Glufosinate-tolerant corn and soy are already following the same path. HB4 wheat would extend this failed, toxic system to a global staple food — deepening chemical dependence, increasing costs for farmers and compounding environmental damage.

Keep reading

Bay Area scientist launches new company with sights on gene-edited babies

Last month, as he announced the launch, he said that Preventive has raised almost $30 million from private funding.

The funding is reportedly coming from some heavy hitters in the tech world, including OpenAI CEO Sam Altman and his husband Oliver Mulherin.

Harrington also said his team included leading experts in the fields of reproductive technology, reproductive medicine and genome-editing.

“Our goal is straightforward,” he wrote, “to determine through rigorous preclinical work whether preventive gene editing can be developed safely to spare families from severe disease.”

Harrington acknowledged the major ethical concerns around the science and the gray areas in the regulatory process, which he said, have opened the field to potentially detrimental outcomes. 

“The combination of limited expert involvement and lack of a clear regulatory pathway has created conditions for fringe groups to take dangerous shortcuts that could harm patients and stifle responsible investigation,” the researchers said, adding, “Given that this technology has the potential to save millions of lives, we do not want this to happen.”

Gene editing can only be used in in vitro fertilization to allow for the first step of genetic testing on an embryo.

“It requires IVF because you have to have the embryo in a dish,” explained Stanford law professor Henry (Hank) Greely, a leading expert on ethical, legal, and social implications in bioscience technologies.

Once a test determines an embryo has the DNA makeup of a genetic disease, for example, like Huntington’s or cystic fibrosis, scientists would then use the DNA editing technique known as Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR, to make alterations to the DNA.

Keep reading

Tech billionaires back startup probing gene-edited ‘designer babies’ despite US ban: report

A Silicon Valley startup backed by OpenAI’s Sam Altman and Coinbase’s Brian Armstrong is pursuing research that some fear could lead to the birth of a genetically engineered baby — a step that’s illegal under US law and banned in most countries, a report said.

The company, Preventive, says its goal is to end hereditary disease by editing human embryos before birth, a claim that has ignited fierce debate over safety, ethics and the specter of designer children, according to the Wall Street Journal.

Preventive, founded earlier this year by gene-editing scientist Lucas Harrington, has raised $30 million and set up headquarters in San Francisco, where it is conducting research on modifying embryos to prevent hereditary disease.

The company says its mission is to prove the technology can be made safe and transparent before any attempt to create a baby is made.

Altman and Armstrong are among the firm’s early investors, the Wall Street Journal reported.

Altman’s husband, Oliver Mulherin, said he led their investment, calling it an effort to help families avoid genetic illness.

Armstrong, who has publicly promoted embryo editing, posted that he was “excited” to back Preventive and argued it is far easier to correct a genetic defect in an embryo than to treat disease later in life.

But federal law prohibits the Food and Drug Administration from considering applications for human trials involving genetically edited embryos used to start pregnancies.

Keep reading